Poisoned panacea

Image
Robert Cole
Last Updated : Feb 05 2013 | 9:59 PM IST

Euro bonds look like such a pleasant panacea. Overstretched sovereign borrowers in the periphery would love them, of course, but they might appeal to fixed income investors, too — at least superficially.

Nasty Greek and Greek-like risks might be diffused and yields might be more generous. Thomson Reuters data shows that today’s gross domestic product (GDP)-weighted amalgam yield on 10-year Euro zone bonds is about four per cent. That’s more than double the yield on UK gilts, US Treasuries and German bunds.

Of course, no such bonds exist yet, and their structure is highly uncertain. But, whatever their final form, potential buyers are likely to have doubts. Unless the Euro zone suddenly becomes more unified, the euro bonds, unlike US Treasuries and UK gilts, would not have the backing of a single clear sovereign government.

The risks of weaker Euro zone members causing a value-destroying crisis would remain and the euro bond contracts would probably be complicated. Investors will hope that Berlin and its hard money stands behind the regional paper, but that will be more of a hope than a certainty. In practice they’ll hardly know what policies they are buying into.

Ironically, investors could suffer if the euro bonds work too well. Suppose they do what they are supposed to — cure the single currency’s funding problem and spur a new round of economic growth.

In a healthier economic environment, inflation might be higher and investors would be less desperate for the safety of solid sovereigns. Bond yields could rise.

A return to the average pre-euro GDP-weighted yield in the t10 years up to 1999 would take the 10-year yield to seven per cent, Thomson Reuters data shows. But even a rise from four per cent to five per cent translates into an eight per cent loss of capital value.

Public debate about euro bonds tends to focus whether new fangled euro bonds can be made to work —politically and economically — for issuers. For the moment the sceptics have the upper hand. If those doubts are overcome, there will also be some sceptical investors to persuade.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 06 2012 | 12:17 AM IST

Next Story